<DOC>
	<DOC>NCT00552994</DOC>
	<brief_summary>In stent neointimal hyperplasia may be less in the Cypher select plus stent compared to the Xience V stent in diabetic patients.</brief_summary>
	<brief_title>Comparison of Coronary Xience V and the Cypher Select+ Stents in Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>All diabetic patients treated with one or more drug eluting stents in the coronary arteries at one of the 5 heart centres in Denmark (Gentofte, Rigshospitalet, Odense, Skejby, Aalborg) can be included in the study. The patient will not participate The patient participates in other randomised stent studies Expected survival &lt; 1 year Allergy to Aspirin, Clopidogrel or Ticlopidine Allergy to Sirolimus or ABT578</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Drug eluting stent</keyword>
	<keyword>Diabetics</keyword>
	<keyword>Intravascular ultrasound</keyword>
	<keyword>Pathophysiologic (neointimal hyperplasia and peri-stent remodeling)</keyword>
</DOC>